Polyelectrolytes and Polyelectrolyte Complexes as Future Antibacterial Agents

Antibiotic-resistance (ABR) poses a critical public health challenge within the broader antimicrobial resistance crisis. This review evaluates the potential of polyelectrolytes (PEs) and polyelectrolyte complexes (PECs) for controlled antibiotic delivery as a strategy to combat ABR and biofilm-related infections. PECs, particularly those incorporating chitosan and other polycations, enhance antibacterial efficacy by disrupting bacterial cell walls and obstructing their nutrient flow. They are also effective in penetrating biofilms and providing sustained drug release. Despite these advantages, there is a need for further in vivo research and clinical trials to validate these findings. This review provides a comprehensive overview of PECs’ potential to advance antibacterial therapies and outlines future research directions to further explore their applications.

Authors

Institutions

Publication Details

Journal
Bacteria
Published
2024-12-03
DOI
https://doi.org/10.3390/bacteria3040031
Citations
7
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
1.46

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polyelectrolytes and Polyelectrolyte Complexes as Future Antibacterial Agents

Adriana Ribeiro, Rahaf Alsayyed, Helena Cabral-Marques
7 citations
Bacteria
Advanced Drug Delivery Systems
1.46
article

Polyelectrolytes and Polyelectrolyte Complexes as Future Antibacterial Agents

Adriana Ribeiro, Rahaf Alsayyed, Helena Cabral-Marques
article en
7 citations

Abstract

Antibiotic-resistance (ABR) poses a critical public health challenge within the broader antimicrobial resistance crisis. This review evaluates the potential of polyelectrolytes (PEs) and polyelectrolyte complexes (PECs) for controlled antibiotic delivery as a strategy to combat ABR and biofilm-related infections. PECs, particularly those incorporating chitosan and other polycations, enhance antibacterial efficacy by disrupting bacterial cell walls and obstructing their nutrient flow. They are also effective in penetrating biofilms and providing sustained drug release. Despite these advantages, there is a need for further in vivo research and clinical trials to validate these findings. This review provides a comprehensive overview of PECs’ potential to advance antibacterial therapies and outlines future research directions to further explore their applications.

BacteriaVol. 3(4)
University of Lisbon (PT)
Fundação para a Ciência e a Tecnologia
Good health and well-being
Openalex Percentile: Top 20%
Advanced Drug Delivery Systems
1.46
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.